Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “obesity”

A Study of SYH2069 Injection in Healthy ParticipantsActive Not Recruiting
NCT07736391Phase 1Updated Jul 30, 2026
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Overweight or Obesity · Diabetes
China
Maternal Smoking Cessation and Pediatric Obesity PreventionRecruiting
NCT03514602NAUpdated Jul 30, 2026
Sponsor: State University of New York at Buffalo
Childhood Obesity · Smoking, Cigarette · Pregnancy
United States
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseCompleted
NCT05882045Phase 3Updated Jul 30, 2026
Sponsor: Eli Lilly and Company
Obesity · Cardiovascular Diseases
United States, Argentina, Australia, Canada, Hungary +5 more
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)Recruiting
NCT04634643N/AUpdated Jul 30, 2026
Sponsor: Yale University
NAFLD
United States
Effect of PDE5 Inhibition on Adipose Metabolism in HumansCompleted
NCT04684589Phase 2Updated Jul 30, 2026
Sponsor: Vanderbilt University Medical Center
Obesity
United States
AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight LossEnrolling By Invitation
NCT07736547NAUpdated Jul 30, 2026
Sponsor: Varol TUNALI
Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities · Overweight (BMI > 25)
Turkey (Türkiye)
OBE2026 - Effect of One Year Intensive Lifestyle Treatment in Children With ISO-BMI Over 30kg/m² and Their Families.Recruiting
NCT07738029NAUpdated Jul 30, 2026
Sponsor: Tampere University Hospital
Obesity & Overweight
Finland
The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for ObesityCompleted
NCT00342732N/AUpdated Jul 30, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obesity · Overweight · Overnutrition
United States
A Study of SYH2082 Injection in Healthy ParticipantsActive Not Recruiting
NCT07736404Phase 1Updated Jul 30, 2026
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.
Overweight or Obesity
China
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the BodyRecruiting
NCT07407348Phase 1Updated Jul 30, 2026
Sponsor: Boehringer Ingelheim
Healthy · Obesity · Overweight
United Kingdom
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightRecruiting
NCT07564414Phase 3Updated Jul 30, 2026
Sponsor: Novo Nordisk A/S
Obesity · Type 2 Diabetes
United States, Argentina, Australia, Austria, Belgium +14 more
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical SurgeryRecruiting
NCT05895968NAUpdated Jul 30, 2026
Sponsor: Xijing Hospital
Cervical Spinal Stenosis · Posterior Cervical Spine Surgery · Barbed Suture
China
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Completed
NCT06548100Phase 3Updated Jul 29, 2026
Sponsor: Regeneron Pharmaceuticals
Generalized Lipodystrophy
United States
Evaluation of Neuregulin-4 (NRG4) Levels in Obese and Non-Obese Patients With Type 2 Diabetes MellitusNot Yet Recruiting
NCT07734558N/AUpdated Jul 29, 2026
Sponsor: GÜLDEN ANATACA
Type 2 Diabetes Mellitus (T2DM) · Obesity Type 2 Diabetes Mellitus · Insulin Resistance
Turkey (Türkiye)
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.Recruiting
NCT07732738NAUpdated Jul 29, 2026
Sponsor: China-Japan Friendship Hospital
Obesity
China
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2DRecruiting
NCT07702890Phase 1, Phase 2Updated Jul 29, 2026
Sponsor: Gubra A/S
Obesity · Type 2 Diabetes
Germany
Induction of Labor in Morbidly Obese PatientsRecruiting
NCT06199154EARLY_Phase 1Updated Jul 29, 2026
Sponsor: University of Maryland, Baltimore
Morbid Obesity · Pregnancy
United States
Dyad Plus Effectiveness/FeasibilityCompleted
NCT04036331NAUpdated Jul 29, 2026
Sponsor: Wake Forest University Health Sciences
Weight Loss · Pediatric Obesity · Overweight Adolescents · Parent-Child Relations
United States
Effect of an Eight Week Dietary Intervention of Pecans on Cardiometabolic Parameters and Serum Cytokines in Individuals With Obesity or OverweightCompleted
NCT07732816NAUpdated Jul 29, 2026
Sponsor: Viterbo University
Obesity & Overweight
The Effects of a Commercially Available Synbiotic on the Gut Microbiome and Cardiometabolic HealthCompleted
NCT07515443NAUpdated Jul 29, 2026
Sponsor: Southern Utah University
Hypertension · Gut Dysbiosis · Overweight , Obesity
United States
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')Recruiting
NCT07195708NAUpdated Jul 29, 2026
Sponsor: Boston Scientific Corporation
Weight Loss
China
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or ObesityRecruiting
NCT07437079Phase 1Updated Jul 29, 2026
Sponsor: Novo Nordisk A/S
Overweight · Obesity
United States
A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise HealthyActive Not Recruiting
NCT07225556Phase 1Updated Jul 29, 2026
Sponsor: Eli Lilly and Company
Overweight · Obesity
United States, Singapore
Effect of Thoracic Mobilization in People With Central ObesityNot Yet Recruiting
NCT07718178NAUpdated Jul 29, 2026
Sponsor: Cairo University
Central Obesity · Ventilatory Function
OverStitch NXT Endoscopic Suture SystemNot Yet Recruiting
NCT07276815NAUpdated Jul 29, 2026
Sponsor: Boston Scientific Corporation
Weight Loss

Previous page Next page